Back

The association between plasma choline and acute myocardial infarction is modified by potential markers of endogenous PPAR activation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention, Cardiovascular Disease in Special Populations Biomarkers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Gard Frodahl Tveitevaag Svingen

Haukeland University Hospital, Bergen (Norway)

29 More presentations in this session

Presentation thumbnail
The selected stress testing protocol is independently associated with mortality irrespective of exercise capacity and comorbidities.
Doctor S. Harb (Cleveland, US)
Abstract Slides
Presentation thumbnail
Exercise-induced cardiac troponin I release and incident cardiovascular morbidity and mortality
Doctor V. Aengevaeren (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Evaluation of endothelial progenitor cells as cardiovascular prognostic biomarkers in hemodialysis patients
Doctor T. Infante (Naples, IT)
Abstract Slides
Presentation thumbnail
Female sex is an independent predictor of mortality in patients with STEMI in Spain: a study in 325,017 episodes over 11 years (2005-2015)
Doctor M. Anguita Sanchez (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Novel cardiotropic AAV variant C102 vectors show superior gene delivery & reduced immunogenicity in non-human primates, transduction of human cardiomyocytes, & correction of Fabry disease phenotype
Doctor G. Brooks (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention, Cardiovascular Disease in Special Populations

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources